Survey on status of perioperative aspirin use in thoracic surgery in China
10.3760/cma.j.cn112434-20240529-00144
- VernacularTitle:中国胸外科围手术期阿司匹林应用现状调查分析
- Author:
Yingze NING
1
;
Weijie ZHU
;
Yang HAO
;
Dong LI
;
Huayu HE
;
Jizheng TANG
;
Songlei OU
;
Chaoyang LIANG
;
Guangliang QIANG
Author Information
1. 北京大学第三医院胸外科，北京 100191
- Keywords:
Aspirin;
Arterial thromboembolic disease;
Thoracic surgery perioperative period;
Questionnaire
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2024;40(11):680-684
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To understand the current status of the use of aspirin in perioperative period of thoracic surgery in China and the awareness of thoracic surgeons on the prevention and treatment of arterial thromboembolic diseases during the perioperative period.Methods:A survey was conducted among thoracic surgeons nationwide using an electronic questionnaire through a software platform from January 20, 2024 to February 29, 2024. The questionnaire mainly included three parts: basic information, aspirin use, and awareness of arterial thromboembolic diseases, with a total of 27 questions.Results:A total of 1318 valid questionnaires were collected, covering all 33 provincial administrative regions except Taiwan. 69.7%(919/1 318) of thoracic surgeons stopped using aspirin for all patients before surgery; differences could be found in the timing of aspirin withdrawal before surgery and resumption after surgery. 65.1%(858/1 318) of surgeons made perioperative medication decisions based on domestic guidelines or consensus, while 20.9%(276/1 318) of surgeons based their decisions on departmental or personal experience. 87.9%(1 159/1 318) of surgeons believed that it is necessary to develop guidelines for the prevention of arterial thromboembolic diseases in the perioperative period of thoracic surgery.Conclusion:The current use strategy of aspirin in the perioperative period of thoracic surgery in China shows a high degree of inconsistency, and there are also significant differences in the awareness of arterial thromboembolic diseases. It is necessary to establish guidelines for the prevention and treatment of arterial thromboembolic diseases in the perioperative period.
